BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2496133)

  • 1. An epidermal growth factor-ricin A chain (EGF-RTA)-resistant mutant and an epidermal growth factor-Pseudomonas endotoxin (EGF-PE)-resistant mutant have distinct phenotypes.
    Banker DE; Pastan I; Gottesman MM; Herschman HR
    J Cell Physiol; 1989 Apr; 139(1):51-7. PubMed ID: 2496133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HeLa cell mutants resistant to epidermal growth factor ricin A-chain conjugate.
    Banker D; Herschman HR
    J Cell Physiol; 1989 Apr; 139(1):42-50. PubMed ID: 2785116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of ligand and antibody-directed ricin A-chain conjugates recognizing the epidermal growth factor receptor.
    Vollmar AM; Banker DE; Mendelsohn J; Herschman HR
    J Cell Physiol; 1987 Jun; 131(3):418-25. PubMed ID: 3496342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization of human KB cell lines resistant to epidermal growth factor: Pseudomonas exotoxin conjugates.
    Amano F; Pastan I; Gottesman MM
    J Cell Physiol; 1988 Jun; 135(3):527-32. PubMed ID: 3260900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor-dependent growth of human KB cells in a defined medium and altered growth factor requirements of KB mutants resistant to EGF-Pseudomonas exotoxin conjugates.
    Amano F; Gottesman MM; Pastan I
    J Cell Physiol; 1988 Jun; 135(3):502-8. PubMed ID: 3294236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of immunotoxins active against ovarian cancer cell lines.
    Pirker R; FitzGerald DJ; Hamilton TC; Ozols RF; Laird W; Frankel AE; Willingham MC; Pastan I
    J Clin Invest; 1985 Sep; 76(3):1261-7. PubMed ID: 3930572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with Pseudomonas exotoxin.
    Akiyama S; Gottesman MM; Hanover JA; Fitzgerald DJ; Willingham MC; Pastan I
    J Cell Physiol; 1984 Sep; 120(3):271-9. PubMed ID: 6086678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant KB cells with decreased EGF receptor expression: biochemical characterization.
    Hwang J; Richert N; Pastan I; Gottesman MM
    J Cell Physiol; 1987 Oct; 133(1):127-34. PubMed ID: 2444605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a potent chimeric toxin by replacement of domain III of Pseudomonas exotoxin with ricin A chain KDEL.
    Pitcher C; Roberts L; Fawell S; Zdanovsky AG; FitzGerald DJ; Lord JM
    Bioconjug Chem; 1995; 6(5):624-9. PubMed ID: 8974463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas exotoxin--immunotoxins.
    FitzGerald DJ; Willingham MC; Pastan I
    Cancer Treat Res; 1988; 37():161-73. PubMed ID: 2908624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the activity of immunotoxins made with either ricin A chain or Pseudomonas exotoxin in human ovarian and epidermoid carcinoma cell lines.
    Pirker R; FitzGerald DJ; Willingham MC; Pastan I
    Cancer Res; 1988 Jul; 48(14):3919-23. PubMed ID: 3260128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates.
    Lyall RM; Hwang JL; Cardarelli C; FitzGerald D; Akiyama S; Gottesman MM; Pastan I
    Cancer Res; 1987 Jun; 47(11):2961-6. PubMed ID: 3494506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A target-specific chimeric toxin composed of epidermal growth factor and Pseudomonas exotoxin A with a deletion in its toxin-binding domain.
    Liao CW; Hseu TH; Hwang J
    Appl Microbiol Biotechnol; 1995 Jul; 43(3):498-507. PubMed ID: 7632400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An EGF-pseudomonas exotoxin A recombinant protein with a deletion in toxin binding domain specifically kills EGF receptor bearing cells.
    Lee CH; Lee EC; Tsai ST; Kung HJ; Liu YC; Hwang J
    Protein Eng; 1993 Jun; 6(4):433-40. PubMed ID: 8332601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas exotoxin A-epidermal growth factor (EGF) mutant chimeric protein as an indicator for identifying amino acid residues important in EGF-receptor interaction.
    Shiah HS; Chen TY; Chang CM; Chow JT; Kung HJ; Hwang J
    J Biol Chem; 1992 Nov; 267(33):24034-40. PubMed ID: 1429738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation by a biscoclaurine alkaloid, cepharanthine, of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin in HeLa cells.
    Shiraishi N; Shimada T; Hagino Y; Kohno K; Kobayashi M; Kuwano M; Akiyama S
    Cancer Res; 1988 Mar; 48(5):1307-11. PubMed ID: 3257717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-Pseudomonas exotoxin A conjugates cytotoxic to human breast cancer cells in vitro.
    Bjorn MJ; Groetsema G; Scalapino L
    Cancer Res; 1986 Jul; 46(7):3262-7. PubMed ID: 3011243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioridazine enhances lysosomal accumulation of epidermal growth factor and toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin.
    Kuratomi Y; Akiyama S; Ono M; Shiraishi N; Shimada T; Ohkuma S; Kuwano M
    Exp Cell Res; 1986 Feb; 162(2):436-48. PubMed ID: 3484705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor-toxin A chain conjugates: EGF-ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxic.
    Cawley DB; Herschman HR; Gilliland DG; Collier RJ
    Cell; 1980 Nov; 22(2 Pt 2):563-70. PubMed ID: 6256086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement by a synthetic isoprenoid of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin.
    Akiyama S; Shiraishi N; Yoshimura A; Nakagawa M; Yamaguchi T; Shimada T; Kuwano M
    Biochem Pharmacol; 1987 Mar; 36(6):861-8. PubMed ID: 3494452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.